Synthetic biology is an exciting and rapidly advancing field of science. It involves the design and construction of new biological components, systems, and organisms. Synthetic Biology Market in terms of revenue was estimated to be worth $11.4 billion in 2022 and is poised to reach $35.7 billion by 2027, growing at a CAGR of 25.6% from 2022 to 2027 according to a new report by MarketsandMarkets™.

Download Free Sample Copy of 'Synthetic Biology market' Report @

Synthetic biology offers a range of potential applications in the healthcare, agricultural, and industrial sectors. In healthcare, synthetic biology can be used to develop new treatments for diseases and to create biobased materials for medical devices. In agriculture, synthetic biology can be used to create new crop varieties that are more resistant to disease and climate change. In industry, synthetic biology can be used to create new bioproducts, including biofuels and bioplastics.

The global synthetic biology market is driven by the increasing demand for new and improved medical treatments, the push for sustainable crop production, and the need for more efficient and cost-effective industrial processes. The growing demand for personalized medicine and the increasing availability of bioinformatics tools and platforms are also contributing to the growth of the market.

The synthetic biology market is expected to continue to grow as new applications are developed and the technology continues to advance. Companies in the market are investing heavily in research and development to expand their product offerings and stay ahead of the competition. As the industry matures, more partnerships and collaborations between companies will be formed, leading to more innovative products and services.

Asia Pacific is likely to grow at higher double digit during the forecast period.

The Asia Pacific region is estimated to grow at the highest CAGR in the synthetic biology market during the forecast period, this is mainly due to factors such the increasing investment in research & development, emergence of new market players in synthetic biology market.

Key Market Players:

Some of the prominent players in the synthetic biology market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Agilent Technologies (US), Novozymes (Denmark), Ginkgo Bioworks (US), Amyris (US), Precigen, Inc. (US), GenScript (China), Twist Bioscience (US), Synthetic Genomics (US), Codexis (US), Synthego (US), Creative Enzymes (US), and among others.

Queries Resolved In This Report:

·         Which will be the specialties at which Market players profiling with intensive designs, financials, and furthermore, ongoing headways should set a nearness?

·         Which will be the foreseen development rates for your own economy out and out and furthermore for each portion inside?

·         Which will be the application and sorts and estimate joined intently by makers?

·         What will be the dangers that will attack growth?

·         The length of the global market opportunity?

·         How does Market share advance vacillations their value from various assembling brands?

Inquire more and share questions if any before the purchase on this report @

Table of Contents: Global Synthetic Biology Market

1 Introduction

2 Market Segmentation

3 Executive Summary

4 Premium Insight

5 Market Overview

6 Covid-19 Impact on Synthetic Biology in Healthcare Industry

7 Global Synthetic Biology Market, by Product Type

8 Global Synthetic Biology Market, by Application

9 Global Synthetic Biology Market, by Geography

10 Global Synthetic Biology Market, Company Landscape

11 Swot Analysis

12 Company Profiles

13 Questionnaire

14 Related Reports

Inquire more and share questions if any before the purchase on this report @

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.


Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441